Skip to content

InfuSystems Holdings, Inc. (INFU) Company Overview

Company Analysis

InfuSystems Holdings, Inc. INFU

A comprehensive view of key metrics, scores, and financial health for InfuSystems Holdings, Inc.

Overview of InfuSystem Holdings, Inc.

INFU ASE
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Micro Cap
InfuSystem Holdings, Inc. (INFU), is a Micro Cap company, in the Medical Instruments & Supplies industry, last closed at $9.14, about 20.7% undervalued vs fair value, +47.2% 1Y return, placing in the top 10% of its sector.
Metrics Rev Growth 6.4% ROE 25.5% Gross Margin 56.0%
USD 9.14
0.99%
(Delayed)
• Vol 90d: 53.8%
52-Week Range
Market Cap
$179.20M
Enterprise Value
$179.44M
Overall Score
Overall
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Good
Valuation
Fair
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Good
Valuation
Fair
Completeness: 82%
Confidence: 53%
Updated: Mar 8
Top Beats

Quick Facts

HQ Rochester Hills, MI
Employees 502
Fiscal year Dec 31

Next Events

Earnings Aug 4 Estimated

Fair Value Snapshot

Bear Base Bull
$10
$11
$12
Current: $9.14 +21% vs base

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$143.4M
6.4%%
Gross Profit
$80.3M
14.1%%
Operating Income (GAAP)
$11.9M
73%%
EBITDA
$25.2M
30.4%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
56.0%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
4
Active Leaks
2/4
Improving
0
High Impact
0
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating InfuSystems Holdings, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
70
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
56
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 97% Coverage
Trade-Off Triangle Visualization A ternary plot showing INFU's balance between Growth (33.2%), Profitability (38.1%), and Safety (28.7%). Growth 33% Safety 29% Profitability 38%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

64th percentile vs peers
65
Key Signals
EPS Growth YoY 1.68 96p Rev Growth YoY 6.4% 51p EPS CAGR 3Y 18.8% 70p Revenue CAGR 3Y 9.3% 52p Asset Growth YoY -2.9% 46p
  • EPS Growth YoY in top 20% of peers (1.68, 96th percentile)
  • FCF Margin in top 20% of peers (16.6%, 88th percentile)
  • Interest Coverage (EBITDA) in top 20% of peers (19.41, 84th percentile)
  • Superior capital returns - 2 return metrics above peer median
  • Growth above peer median with strong metric coverage (90%)

No significant risks identified for this axis.

Profitability

74th percentile vs peers
74
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

56th percentile vs peers
56
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for InfuSystems Holdings, Inc..

Loading scenario defaults...
Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$11.03
- - -
+20.7% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000